You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Transdermal Delivery of Buprenorphine Prodrugs

    SBC: ALLTRANZ, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Currently buprenorphine (BUP) is used in the treatment of opioid abuse and for pain management. It can also be used improperly and abused as an opioid. In the United States, buprenorphine is marketed in sublingual and injectable forms. While the drug provides effective treatment, these forms of drug delivery are not desirable because of their peak plasma level ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  2. Exosomal microRNA profiles as diagnostic biomarkers of ovarian cancer

    SBC: TEKSHIFA, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Detection of ovarian cancer at Stage I results in 5-year survivals of greater than 90%; however, only 23% of ovarian cancers are diagnosed early, with 67% being diagnosed with metastatic disease. Thus, new markers are being sought to accurate identify patients with ovarian cancer, particularly in early stage. Emerging evidence suggests the potential involvement ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  3. Active Distributed Electrode Array Network for Electrical Stimulation Therapy

    SBC: CUSTOMKYNETICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Transcutaneous electrical stimulation applications involving high numbers of stimulated muscles have been an area of growing interest in recent years. customKYnetics has been approached in recent months by research groups and stimulation application developers requesting high channel count stimulation devices for use in their spinal cord injury rehabilitation ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  4. Delivery of Polyphenols in Gum for Treatment of Gingivitis

    SBC: FOUR TIGERS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Periodontitis represents a polymicrobial disease, in which a complex microbial ecology that matures in biofilms in the subgingival sulcus triggers a chronic immunoinflammatory lesion that destroys soft and hard tissues of the periodontium. The ability to identify therapeutics, to enable more effective control and/or prevention of gingival inflammation, is a cr ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  5. Ultra-soft atomic force microscope (USAFM) technology using nano-cantilevers for

    SBC: NAUGANNEEDLES, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): NaugaNeedles LLC in collaboration with researchers from Purdue University are proposing to develop an advanced new Ultra-Soft Atomic Force Microscope (USAFM). This USAFM can gently create images of soft biological samples in buffer solutions with sub-picoNewton (pN) forces and sub-nm lateral resolution. This new AFM technology will have a high-bandwidth to ensu ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  6. Natural Product Protease Inhibitors: Therapeutics for Virulence of Oral Pathogens

    SBC: ORACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Oral infections associated with the gingival margin and subgingival sulcus lead to host inflammatory responses. Gingivitis is primarily a response to the bacteria in plaque. This disease affects nearly everyone in the population, at some time during their life. Periodontitis is a multifactorial disease that encompasses the hard and soft tissue, microbial col ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  7. Multimedia Storybook about Technology and Disabilities

    SBC: ORCCA TECHNOLOGY, INC.            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  8. A non-surgical embryo transfer (NSET) device for producing gene-modified mice

    SBC: PARATECHS CORP            Topic: N/A

    DESCRIPTION (provided by applicant): The ability to genetically modify mice through methods of gene transfer in fertilized mouse embryos (transgenic mice) or gene modification in embryonic stem (ES) cells (gene targeting) has dramatically increased the value and use of mice in biomedical research. . The production of gene-modified mice requires the surgical transfer of embryos into female mice. T ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  9. Potent antimicrobial peptides from carrion beetles

    SBC: PARATECHS CORP            Topic: N/A

    DESCRIPTION (provided by applicant): Antibiotic resistant pathogenic microbes are responsible for thousands of human fatalities worldwide each year. The heightening risk of emerging pathogen resistance in clinical settings promotes the need for discovery and development of new antibiotics with a high degree of activity, potency, and specificity. ParaTechs Corporation has identified proteinaceous a ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  10. Portable pneumatic driver for counterpulsation therapy

    SBC: SCR, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): SCR, Inc. (Louisville, KY) is developing a chronic implantable CPD system to treat HF patients who may be responsive to long-term counterpulsation support. The CPD has been developed for superficial implantation via a pacemaker incision without the need to enter the chest and enables complete patient mobility. The CPD is a 32-ml stroke volume polyurethane-lined ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government